Emma De Winton

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Hisham Mehanna, Max Robinson, A. Hartley et al. · The Lancet · 2018 · 988 citations · Full text

A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia

DC Dale, MA Bonilla, MW Davis et al. · Blood · 1993 · 475 citations · Full text

Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial

Amelia Clive, Hazel Taylor, Lee Dobson et al. · The Lancet Oncology · 2016 · 164 citations · Full text

The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer

Emma De Winton, Alexander G. Heriot, Michael Ng et al. · British Journal of Cancer · 2009 · 113 citations · Full text

Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial

Christopher M. Nutting, Laura Finneran, Justin Roe et al. · The Lancet Oncology · 2023 · 93 citations · Full text